198 related articles for article (PubMed ID: 19699734)
1. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes.
Hie M; Yamazaki M; Tsukamoto I
Eur J Pharmacol; 2009 Oct; 621(1-3):1-9. PubMed ID: 19699734
[TBL] [Abstract][Full Text] [Related]
2. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
3. Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats.
Iitsuka N; Hie M; Tsukamoto I
Eur J Pharmacol; 2013 Aug; 714(1-3):41-7. PubMed ID: 23735664
[TBL] [Abstract][Full Text] [Related]
4. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells.
Paul S; Lee JC; Yeh LC
Growth Factors; 2009 Apr; 27(2):121-31. PubMed ID: 19180354
[TBL] [Abstract][Full Text] [Related]
6. Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo.
Iitsuka N; Hie M; Nakanishi A; Tsukamoto I
Int J Mol Med; 2012 Jul; 30(1):165-72. PubMed ID: 22576626
[TBL] [Abstract][Full Text] [Related]
7. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
10. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
[TBL] [Abstract][Full Text] [Related]
11. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Hie M; Tsukamoto I
Int J Mol Med; 2010 Oct; 26(4):611-8. PubMed ID: 20818503
[TBL] [Abstract][Full Text] [Related]
13. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
[TBL] [Abstract][Full Text] [Related]
14. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.
Geng DC; Zhu XS; Mao HQ; Meng B; Chen L; Yang HL; Xu YZ
J Biomed Mater Res A; 2011 Dec; 99(4):516-22. PubMed ID: 21913318
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
16. Afamin stimulates osteoclastogenesis and bone resorption via Gi-coupled receptor and Ca2+/calmodulin-dependent protein kinase (CaMK) pathways.
Kim BJ; Lee YS; Lee SY; Park SY; Dieplinger H; Yea K; Lee SH; Koh JM; Kim GS
J Endocrinol Invest; 2013 Nov; 36(10):876-82. PubMed ID: 23698732
[TBL] [Abstract][Full Text] [Related]
17. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
18. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M
PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029
[TBL] [Abstract][Full Text] [Related]
19. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption.
Zhang Y; Li Q; Li X; Wan HY; Wong MS
Br J Nutr; 2010 Oct; 104(7):965-71. PubMed ID: 20487580
[TBL] [Abstract][Full Text] [Related]
20. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
Rodrigues WF; Madeira MF; da Silva TA; Clemente-Napimoga JT; Miguel CB; Dias-da-Silva VJ; Barbosa-Neto O; Lopes AH; Napimoga MH
Br J Pharmacol; 2012 Apr; 165(7):2140-51. PubMed ID: 21950592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
